{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:11:39Z","timestamp":1792192299295,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["437037\/2018-5 (CLMF), 440755\/2018-2 and 434821\/2018-7 (CP)"],"award-info":[{"award-number":["437037\/2018-5 (CLMF), 440755\/2018-2 and 434821\/2018-7 (CP)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["437037\/2018-5 (CLMF), 440755\/2018-2 and 434821\/2018-7 (CP)"],"award-info":[{"award-number":["437037\/2018-5 (CLMF), 440755\/2018-2 and 434821\/2018-7 (CP)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Penile cancer is one of the most aggressive male tumors. Although it is preventable, the main etiologic causes are lifestyle behaviors and viral infection, such as human papillomavirus (HPV). Long-term epigenetic changes due to environmental factors change cell fate and promote carcinogenesis, being an important marker of prognosis. We evaluated epidemiological aspects of penile squamous cell carcinoma (SCC) and the prevalence of HPV infection using high-risk HPV (hrHPV) and p16<jats:sup>INK4A<\/jats:sup> expression of 224 participants. Global DNA methylation was evaluated through 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The incidence of HPV was 53.2% for hrHPV and 22.32% for p16<jats:sup>INK4a<\/jats:sup>. hrHPV was not related to systemic or lymph node metastasis and locoregional recurrence, nor influenced the survival rate. P16<jats:sup>INK4a<\/jats:sup> seems to be a protective factor for death, which does not affect metastasis or tumor recurrence. Lymph node and systemic metastases and locoregional recurrence increase the risk of death. An increased 5mC mark was observed in penile SCC regardless of HPV infection. However, there is a reduction of the 5hmC mark for p16<jats:sup>INK4a<\/jats:sup>\u2009+\u2009(<jats:italic>P<\/jats:italic>\u2009=\u20090.024). Increased 5mC\/5hmC ratio (&gt;\u20091) was observed in 94.2% of penile SCC, irrespective of HPV infection. Despite the increase in 5mC, it seems not to affect the survival rate (HR\u2009=\u20091.06; 95% CI 0.33\u20133.38).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>P16<jats:sup>INK4a<\/jats:sup> seems to be a good prognosis marker for penile SCC and the increase in 5mC, an epigenetic mark of genomic stability, may support tumor progression leading to poor prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-022-01360-1","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T12:03:39Z","timestamp":1666699419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["HPV infection and 5mC\/5hmC epigenetic markers in penile squamous cell carcinoma: new insights into prognostics"],"prefix":"10.1186","volume":"14","author":[{"given":"Renan da Silva","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Gustavo","family":"Hirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Pascoalino","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J\u00falia Barbosa","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Joyce de Lima","family":"Silva-Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayrine Silveira de","family":"Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Negreiros Nunes","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel Odorico de","family":"Moraes Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlindo de Alencar Araripe","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Ven\u00edcio Alves","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia do \u00d3","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana Libardi Miranda","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin."},{"key":"1360_CR2","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1590\/1413-81232018238.17692016","volume":"23","author":"MAC de Souza","year":"2018","unstructured":"de Souza MAC, Zacchi SR, Viana KCG, de Souza CB, Zandonade E, Amorim MHC. Survival analysis of penile cancer patients treated at a tertiary oncology hospital. Cienc e Saude Coletiva. 2018;23:2479\u201386.","journal-title":"Cienc e Saude Coletiva."},{"key":"1360_CR3","first-page":"1","volume":"2","author":"C Eduardo","year":"2017","unstructured":"Eduardo C, Cardona M, Garc\u00eda-perdomo HA. Incidence of penile cancer worldwide: systematic review and meta-analysis. Pan Am J Public Heal. 2017;2:1\u201310.","journal-title":"Pan Am J Public Heal."},{"key":"1360_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41585-021-00557-y","volume":"19","author":"M Bandini","year":"2022","unstructured":"Bandini M, Ahmed M, Basile G, Watkin N, Master V, Zhu Y, et al. A global approach to improving penile cancer care. Nat Rev Urol. 2022;19:231\u20139.","journal-title":"Nat Rev Urol."},{"key":"1360_CR5","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.tranon.2021.101326","volume":"16","author":"HO Brito","year":"2022","unstructured":"Brito HO, de Calixto JRR, Medeiros R, da Costa RMG. Comment on DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells. Transl Oncol. 2022;16:2021\u20132.","journal-title":"Transl Oncol."},{"key":"1360_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2490-9-8","volume":"9","author":"SB Maddineni","year":"2009","unstructured":"Maddineni SB, Lau MM, Sangar VK. Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol. 2009;9:1\u20136.","journal-title":"BMC Urol."},{"key":"1360_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MOU.0000000000000581","volume":"29","author":"A Douglawi","year":"2019","unstructured":"Douglawi A, Masterson TA. Penile cancer epidemiology and risk factors: a contemporary review. Curr Opin Urol. 2019;29:145\u20139.","journal-title":"Curr Opin Urol."},{"key":"1360_CR8","first-page":"3","volume":"96","author":"R Baraziol","year":"2017","unstructured":"Baraziol R, Schiavon M, Fraccalanza E, De Giorgi G. Melanoma in situ of penis: a very rare entity. Med (United States). 2017;96:3\u20136.","journal-title":"Med (United States)"},{"key":"1360_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","volume":"27","author":"MCG Bleeker","year":"2009","unstructured":"Bleeker MCG, Heideman DAM, Snijders PJF, Horenblas S, Dillner J, Meijer CJLM. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27:141\u201350.","journal-title":"World J Urol."},{"key":"1360_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.currproblcancer.2015.03.010","volume":"39","author":"M Christodoulidou","year":"2015","unstructured":"Christodoulidou M, Sahdev V, Houssein S, Muneer A. Epidemiology of penile cancer. Curr Probl Cancer [Internet]. 2015;39:126\u201336. https:\/\/doi.org\/10.1016\/j.currproblcancer.2015.03.010.","journal-title":"Curr Probl Cancer [Internet]."},{"key":"1360_CR11","first-page":"237","volume":"19","author":"PFM de J\u00fanior","year":"2018","unstructured":"de J\u00fanior PFM, Silva EHV, Moura KL, de Aquino YF, Weller M. Increased risk of penile cancer among men working in agriculture. Asian Pacific J Cancer Prev. 2018;19:237\u201341.","journal-title":"Asian Pacific J Cancer Prev."},{"key":"1360_CR12","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1111\/j.1743-6109.2011.02512.x","volume":"9","author":"SC de Zequi","year":"2012","unstructured":"de Zequi SC, Guimar\u00e3es GC, da Fonseca FP, Ferreira U, de Matheus WE, Reis LO, et al. Sex with animals (SWA): behavioral characteristics and possible association with penile cancer. A multicenter study. J Sex Med. 2012;9:1860\u20137.","journal-title":"J Sex Med."},{"key":"1360_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-59831-5","volume":"10","author":"CB Vieira","year":"2020","unstructured":"Vieira CB, Feitoza L, Pinho J, Teixeira-J\u00fanior A, Lages J, Calixto J, et al. Profile of patients with penile cancer in the region with the highest worldwide incidence. Sci Rep. 2020;10:1\u20137.","journal-title":"Sci Rep."},{"key":"1360_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","volume":"26","author":"E Archier","year":"2012","unstructured":"Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Ma\u00eetre M, et al. Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:22\u201331.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"1360_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/ijc.21009","volume":"116","author":"JR Daling","year":"2005","unstructured":"Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116:606\u201316.","journal-title":"Int J Cancer."},{"key":"1360_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12894-016-0161-7","volume":"16","author":"KT Barnes","year":"2016","unstructured":"Barnes KT, McDowell BD, Button A, Smith BJ, Lynch CF, Gupta A. Obesity is associated with increased risk of invasive penile cancer. BMC Urol [Internet]. 2016;16:7\u201310. https:\/\/doi.org\/10.1186\/s12894-016-0161-7.","journal-title":"BMC Urol [Internet]"},{"key":"1360_CR17","first-page":"105","volume":"2","author":"EJ Schoen","year":"2000","unstructured":"Schoen EJ, Oehrli M, Colby C, Machin G. The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics. 2000;2:105.","journal-title":"Pediatrics."},{"key":"1360_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518\u201327.","journal-title":"N Engl J Med."},{"key":"1360_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1440-1827.2008.02259.x","volume":"58","author":"N Yanagawa","year":"2008","unstructured":"Yanagawa N, Osakabe M, Hayashi M, Tamura G, Motoyama T. Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men. Pathol Int. 2008;58:477\u201382.","journal-title":"Pathol Int."},{"key":"1360_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/path.1394","volume":"201","author":"E Ferreux","year":"2003","unstructured":"Ferreux E, Lont AP, Horenblas S, Gallee MPW, Raaphorst FM, von Knebel DM, et al. Evidence for at least three alternative mechanisms targeting the p16INK4A\/cyclin D\/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol. 2003;201:109\u201318.","journal-title":"J Pathol."},{"key":"1360_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.01521","volume":"10","author":"W Gu","year":"2020","unstructured":"Gu W, Zhang P, Zhang G, Zhou J, Ding X, Wang Q, et al. Importance of HPV in Chinese penile cancer: a contemporary multicenter study. Front Oncol. 2020;10:1\u20138.","journal-title":"Front Oncol."},{"key":"1360_CR22","first-page":"8102","volume":"15","author":"D Takamoto","year":"2018","unstructured":"Takamoto D, Kawahara T, Kasuga J, Sasaki T, Yao M, Yumura Y, et al. The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization. Oncol Lett. 2018;15:8102\u20136.","journal-title":"Oncol Lett."},{"key":"1360_CR23","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/infdis\/jis228","volume":"205","author":"M Blomberg","year":"2012","unstructured":"Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer: a danish study of nearly 50000 patients with genital warts. J Infect Dis. 2012;205:1544\u201353.","journal-title":"J Infect Dis."},{"key":"1360_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/ijc.21961","volume":"119","author":"AP Lont","year":"2006","unstructured":"Lont AP, Kroon BK, Horenblas S, Gallee MPW, Berkhof J, Meijer CJLM, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119:1078\u201381.","journal-title":"Int J Cancer."},{"key":"1360_CR25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/JU.0000000000000584","volume":"203","author":"B Wang","year":"2019","unstructured":"Wang B, Gu W, Wan F, Wei Y, Xiao W, Lu X, et al. Prognosis of the 8th TNM staging system for penile cancer and refinement of prognostication by incorporating high risk human papillomavirus status. J Urol. 2019;203:562\u20139.","journal-title":"J Urol."},{"key":"1360_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10147-016-1005-x","volume":"21","author":"D Sano","year":"2016","unstructured":"Sano D, Oridate N. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Int J Clin Oncol. 2016;21:819\u201326.","journal-title":"Int J Clin Oncol."},{"key":"1360_CR27","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-03-0565","volume":"10","author":"P Melsheimer","year":"2004","unstructured":"Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, Von Knebel DM. DNA aneuploidy and integration of human papillomavirus type 16 E6\/E7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res. 2004;10:3059\u201363.","journal-title":"Clin Cancer Res."},{"key":"1360_CR28","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1073\/pnas.1009933108","volume":"108","author":"ME McLaughlin-Drubin","year":"2011","unstructured":"McLaughlin-Drubin ME, Crum CP, M\u00fcnger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A. 2011;108:2130\u20135.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1360_CR29","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1038\/sj.onc.1206896","volume":"22","author":"A Bernat","year":"2003","unstructured":"Bernat A, Avvakumov N, Mymryk JS, Banks L. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene. 2003;22:7871\u201381.","journal-title":"Oncogene."},{"key":"1360_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21641\/los.15.1.58","volume":"15","author":"P Sen","year":"2018","unstructured":"Sen P, Ganguly P, Ganguly N. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer. Oncol Lett. 2018;15:11\u201322.","journal-title":"Oncol Lett."},{"key":"1360_CR31","first-page":"1599","volume":"24","author":"P Lai","year":"2010","unstructured":"Lai P, Chun CLAY, Wing PT, Tsun YT, Ngai N, Chiu T, Huang Y. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol Rep. 2010;24:1599\u2013604.","journal-title":"Oncol Rep."},{"key":"1360_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov."},{"key":"1360_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RDM Steenbergen","year":"2014","unstructured":"Steenbergen RDM, Snijders PJF, Heideman DAM, Meijer CJLM. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14:395\u2013405.","journal-title":"Nat Rev Cancer."},{"key":"1360_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Brudno Y, Agarwal S, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324:930\u20135.","journal-title":"Science."},{"key":"1360_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2217\/epi.13.69","volume":"5","author":"A Laird","year":"2013","unstructured":"Laird A, Thomson JP, Harrison DJ, Meehan RR. 5-hydroxymethylcytosine profiling as an indicator of cellular state. Epigenomics. 2013;5:655\u201369.","journal-title":"Epigenomics."},{"key":"1360_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139.","journal-title":"CA Cancer J Clin."},{"key":"1360_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/PAS.0b013e318203cdba","volume":"35","author":"AL Cubilla","year":"2011","unstructured":"Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, et al. Value of p16INK4a in the pathology of invasive penile Squamous cell carcinomas: a report of 202 cases. Am J Surg Pathol. 2011;35:253\u201361.","journal-title":"Am J Surg Pathol."},{"key":"1360_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1590\/S1677-5538.IBJU.2013.05.01","volume":"39","author":"ZS De C\u00e1ssio","year":"2013","unstructured":"De C\u00e1ssio ZS. Penile cancer: the importance of prevention. Int Braz J Urol. 2013;39:611\u20133.","journal-title":"Int Braz J Urol."},{"key":"1360_CR39","doi-asserted-by":"publisher","first-page":"eAO5577","DOI":"10.31744\/einstein_journal\/2020AO5577","volume":"18","author":"F Korkes","year":"2020","unstructured":"Korkes F, Rodrigues AFS, Baccaglini W, Cunha FTS, Slongo J, Spiess P, et al. Penile cancer trends and economic burden in the Brazilian public health system. Einstein (Sao Paulo). 2020;18:eAO5577.","journal-title":"Einstein (Sao Paulo)."},{"key":"1360_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-018-0365-0","volume":"18","author":"RWP Coelho","year":"2018","unstructured":"Coelho RWP, Pinho JD, Moreno JS, Garbis DVEO, Do Nascimento AMT, Larges JS, et al. Penile cancer in Maranh\u00e3o, Northeast Brazil: the highest incidence globally? BMC Urol. 2018;18:1\u20137.","journal-title":"BMC Urol"},{"key":"1360_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1590\/S1677-55382011000200010","volume":"37","author":"L Koifman","year":"2011","unstructured":"Koifman L, Vides AJ, Koifman N, Carvalho JP, Ornellas AA. Epidemiological aspects of penile cancer in Rio de Janeiro: evaluation of 230 cases. Int Braz J Urol. 2011;37:231\u201340.","journal-title":"Int Braz J Urol"},{"key":"1360_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3892\/ol.2015.3221","volume":"10","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Gu WJ, Wang HK, Gu CY, Ye DW. Surgical treatment of primary disease for penile squamous cell carcinoma: a surveillance, epidemiology, and end results database analysis. Oncol Lett. 2015;10:84\u201392.","journal-title":"Oncol Lett"},{"key":"1360_CR43","doi-asserted-by":"crossref","unstructured":"Sewell J, Ranasinghe W, De Silva D, Ayres B, Ranasinghe T, Hounsome L, et al. Trends in penile cancer: a comparative study between Australia, England and Wales, and the US. Springerplus. Springer International Publishing; 2015;4.","DOI":"10.1186\/s40064-015-1191-4"},{"key":"1360_CR44","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/iju.14247","volume":"27","author":"K Tanaka","year":"2020","unstructured":"Tanaka K, Kandori S, Nitta S, Chihara I, Kojo K, Nagumo Y, et al. Characteristics of penile cancer in Japan: an analysis of nationwide hospital-based cancer registry data. Int J Urol. 2020;27:538\u201342.","journal-title":"Int J Urol"},{"key":"1360_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","volume":"458","author":"M Poetsch","year":"2011","unstructured":"Poetsch M, Hemmerich M, Kakies C, Kleist B, Wolf E, Vom Dorp F, et al. Alterations in the tumor suppressor gene p16 INK4A are associated with aggressive behavior of penile carcinomas. Virchows Arch. 2011;458:221\u20139.","journal-title":"Virchows Arch"},{"key":"1360_CR46","first-page":"1","volume":"13","author":"MV De Andrade","year":"2018","unstructured":"De Andrade MV, Pinho JD, J\u00fanior AALT, Nogueira LR, Silva FF, Maulen VE, et al. P16INK4a expression in patients with penile cancer. PLoS ONE. 2018;13:1\u201313.","journal-title":"PLoS ONE"},{"key":"1360_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen TB, Sand FL, Rasmussen CL, Albieri V, Toft BG, Norrild B, et al. Prevalence of human papillomavirus DNA and p16 INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2019;20:145\u201358.","journal-title":"Lancet Oncol"},{"key":"1360_CR48","doi-asserted-by":"publisher","first-page":"53.e1","DOI":"10.1016\/j.urolonc.2013.08.010","volume":"32","author":"A Flaherty","year":"2014","unstructured":"Flaherty A, Kim T, Giuliano A, Magliocco A, Hakky TS, Pagliaro LC, et al. Implications for human papillomavirus in penile cancer. Urol Oncol Semin Orig Investig. 2014;32:53.e1-53.e8. https:\/\/doi.org\/10.1016\/j.urolonc.2013.08.010.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"1360_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.606335","volume":"10","author":"B Xing","year":"2021","unstructured":"Xing B, Guo J, Sheng Y, Wu G, Zhao Y. Human papillomavirus-negative cervical cancer: a comprehensive review. Front Oncol. 2021;10:1\u20138.","journal-title":"Front Oncol"},{"key":"1360_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13193-012-0195-6","volume":"4","author":"J Purkayastha","year":"2013","unstructured":"Purkayastha J. Multiple cutaneous metastasis from carcinoma of the penis-report of two cases. Indian J Surg Oncol. 2013;4:73\u20135.","journal-title":"Indian J Surg Oncol"},{"key":"1360_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrurol.2017.47","volume":"14","author":"A Leone","year":"2017","unstructured":"Leone A, Diorio GJ, Pettaway C, Master V, Spiess PE. Contemporary management of patients with penile cancer and lymph node metastasis. Nat Rev Urol. 2017;14:335\u201347.","journal-title":"Nat Rev Urol"},{"key":"1360_CR52","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1590\/S1413-81232010000700018","volume":"15","author":"AAS da Reis","year":"2010","unstructured":"da Reis AAS, de Paula LB, de Paula AAP, Saddi VA, da Cruz AD. Aspectos cl\u00ednico-epidemiol\u00f3gicos associados ao c\u00e2ncer de p\u00eanis. Cien Saude Colet. 2010;15:1105\u201311.","journal-title":"Cien Saude Colet."},{"key":"1360_CR53","doi-asserted-by":"publisher","first-page":"785","DOI":"10.21037\/tau.2017.05.19","volume":"6","author":"A Douglawi","year":"2017","unstructured":"Douglawi A, Masterson TA. Updates on the epidemiology and risk factors for penile cancer. Transl Androl Urol. 2017;6:785\u201390.","journal-title":"Transl Androl Urol"},{"key":"1360_CR54","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-14-1656","volume":"21","author":"A Feber","year":"2015","unstructured":"Feber A, Arya M, De Winter P, Saqib M, Nigam R, Malone PR, et al. Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer. Clin Cancer Res. 2015;21:1196\u2013206.","journal-title":"Clin Cancer Res"},{"key":"1360_CR55","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1631\/jzus.B1600314","volume":"18","author":"Y Tian","year":"2017","unstructured":"Tian Y, Lin A, Gan M, Wang H, Yu D, Lai C, et al. Global changes of 5-hydroxymethylcytosine and 5-methylcytosine from normal to tumor tissues are associated with carcinogenesis and prognosis in colorectal cancer. J Zhejiang Univ Sci B. 2017;18:747\u201356.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1360_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-018-0540-x","volume":"10","author":"TM Storebjerg","year":"2018","unstructured":"Storebjerg TM, Strand SH, H\u00f8yer S, Lynnerup A-S, Borre M, \u00d8rntoft TF, et al. Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer. Clin Epigenet. 2018;10:1\u201316.","journal-title":"Clin Epigenet"},{"key":"1360_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/MED.0000000000000037","volume":"21","author":"S Azzi","year":"2014","unstructured":"Azzi S, Habib WA, Netchine I. Beckwith-Wiedemann and Russell-Silver Syndromes: from new molecular insights to the comprehension of imprinting regulation. Curr Opin Endocrinol Diabetes Obes. 2014;21:30\u20138.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1360_CR58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nm.2305","volume":"17","author":"M Rodr\u00edguez-Paredes","year":"2011","unstructured":"Rodr\u00edguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011;17:330\u20139.","journal-title":"Nat Med"},{"key":"1360_CR59","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.prp.2017.04.016","volume":"213","author":"Y Wang","year":"2017","unstructured":"Wang Y, Hu H, Wang Q, Li Z, Zhu Y, Zhang W, et al. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: an immunohistochemical study in 95 patients. Pathol Res Pract. 2017;213:969\u201374. https:\/\/doi.org\/10.1016\/j.prp.2017.04.016.","journal-title":"Pathol Res Pract"},{"key":"1360_CR60","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/21691401.2019.1634578","volume":"47","author":"J Wang","year":"2019","unstructured":"Wang J, Su Y, Tian Y, Ding Y, Wang X. Characterization of DNA hydroxymethylation profile in cervical cancer. Artif Cells Nanomed Biotechnol. 2019;47:2706\u201314.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1360_CR61","first-page":"1","volume":"2","author":"GM Cavalcante","year":"2020","unstructured":"Cavalcante GM, Borges DP, De Oliveira RTG, Furtado CLM, Alves APNN, Sousa AM, et al. Tissue methylation and demethylation influence translesion synthesis DNA polymerases (TLS) contributing to the genesis of chromosomal abnormalities in myelodysplastic syndrome. J Clin Pathol. 2020;2:1\u20139.","journal-title":"J Clin Pathol."},{"key":"1360_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40246-020-00265-5","volume":"14","author":"T Xu","year":"2020","unstructured":"Xu T, Gao H. Hydroxymethylation and tumors: Can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment? Hum Genom. 2020;14:1\u201310.","journal-title":"Hum Genom"},{"key":"1360_CR63","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/cr.2017.106","volume":"27","author":"CX Song","year":"2017","unstructured":"Song CX, Yin S, Ma L, Wheeler A, Chen Y, Zhang Y, et al. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Res. 2017;27:1231\u201342.","journal-title":"Cell Res"},{"key":"1360_CR64","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/cr.2017.121","volume":"27","author":"W Li","year":"2017","unstructured":"Li W, Zhang X, Lu X, You L, Song Y, Luo Z, et al. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res. 2017;27:1243\u201357. https:\/\/doi.org\/10.1038\/cr.2017.121.","journal-title":"Cell Res"},{"key":"1360_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00965-8","volume":"12","author":"S Liu","year":"2020","unstructured":"Liu S, de Medeiros MC, Fernandez EM, Zarins KR, Cavalcante RG, Qin T, et al. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers. Clin Epigenet. 2020;12:1\u201314. https:\/\/doi.org\/10.1186\/s13148-020-00965-8.","journal-title":"Clin Epigenet"},{"key":"1360_CR66","doi-asserted-by":"publisher","first-page":"201","DOI":"10.20517\/2394-4722.2015.67","volume":"2","author":"P Tulay","year":"2016","unstructured":"Tulay P, Serakinci N. The role of human papillomaviruses in cancer progression. J Cancer Metastasis Treat. 2016;2:201.","journal-title":"J Cancer Metastasis Treat"},{"key":"1360_CR67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1360_CR68","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","volume":"14","author":"CL Miranda Furtado","year":"2019","unstructured":"Miranda Furtado CL, Dos Santos Luciano MC, Da Silva Santos R, Furtado GP, Moraes MO, Pessoa C. Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics. 2019;14:1164\u201376. https:\/\/doi.org\/10.1080\/15592294.2019.1640546.","journal-title":"Epigenetics"},{"key":"1360_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2009","unstructured":"Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2009;31:27\u201336.","journal-title":"Carcinogenesis"},{"key":"1360_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-015-0082-4","volume":"7","author":"H Kuasne","year":"2015","unstructured":"Kuasne H, de Syllos C\u00f3lus IM, Busso AF, Hernandez-Vargas H, Barros-Filho MC, Marchi FA, et al. Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers. Clin Epigenet. 2015;7:1\u201310. https:\/\/doi.org\/10.1186\/s13148-015-0082-4.","journal-title":"Clin Epigenet"},{"key":"1360_CR71","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18:517\u201334. https:\/\/doi.org\/10.1038\/nrg.2017.33.","journal-title":"Nat Rev Genet."},{"key":"1360_CR72","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41388-022-02213-0","volume":"41","author":"CG Liao","year":"2022","unstructured":"Liao CG, Liang XH, Ke Y, Yao L, Liu M, Liu ZK, et al. Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis. Oncogene. 2022;41:1780\u201394.","journal-title":"Oncogene."},{"key":"1360_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.01152","volume":"10","author":"S Romero-Garcia","year":"2020","unstructured":"Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA methylation in the resistance to therapy in solid tumors. Front Oncol. 2020;10:1\u201320.","journal-title":"Front Oncol."},{"key":"1360_CR74","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/jnci\/djh183","volume":"96","author":"BJM Braakhuis","year":"2004","unstructured":"Braakhuis BJM, Snijders PJF, Keune WJH, Meijer CJLM, Ruijter-Schippers HJ, Leemans CR, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst. 2004;96:998\u20131006.","journal-title":"J Natl Cancer Inst."},{"key":"1360_CR75","doi-asserted-by":"publisher","first-page":"927","DOI":"10.21873\/invivo.11331","volume":"32","author":"K Kida","year":"2018","unstructured":"Kida K, Terada T, Nobuhiro UWA, Omori Y, Fujii T, Tomita Y, et al. Relationship between p16 expression and prognosis in patients with oropharyngeal cancer undergoing surgery. In Vivo (Brooklyn). 2018;32:927\u201335.","journal-title":"In Vivo (Brooklyn)"},{"key":"1360_CR76","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.radonc.2014.11.032","volume":"113","author":"P Lassen","year":"2014","unstructured":"Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol. 2014;113:310\u20136. https:\/\/doi.org\/10.1016\/j.radonc.2014.11.032.","journal-title":"Radiother Oncol."},{"key":"1360_CR77","doi-asserted-by":"crossref","unstructured":"Hashmi AA, Younus N, Naz S, Irfan M, Hussain Z, Shaikh ST, et al. p16 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: Association With Prognostic Parameters. Cureus. 2020;12.","DOI":"10.7759\/cureus.8601"},{"key":"1360_CR78","first-page":"1351","volume":"18","author":"Q Shi","year":"2019","unstructured":"Shi Q, Xu L, Yang R, Meng Y, Qiu L. Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions. Oncol Lett. 2019;18:1351\u20135.","journal-title":"Oncol Lett."}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-022-01360-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T17:05:17Z","timestamp":1667063117000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-022-01360-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1186\/s13148-022-01360-1","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by our Institutional Review Board (process number 2.427.846). The samples are kept in the custody of the Cancer Institute of Cear\u00e1 Biobank, as well as the data from the medical records and the histopathological blocks. All patients agreed to the Informed Consent Form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}